Furthermore, the prognosis of patients with GBM was poor in the GBM patients with ZBTB7A downregulation (Fig. 1g) according to Kaplan–Meier survival analysis based on the TCGA-GBMLGG dataset. The gene discussed is ZBTB7A; the disease is glioblastoma.